Ginger exerts digestive chemoprevention via 5 anti-tumoral pathways: tumor NF-κB↓ (tumor cell survival↓ — Bcl-2/Bcl-xL/survivin↓); induced apoptosis (caspase-3/9↑, Bax/Bcl-2↑); AMPK→mTORC1↓ (tumor proliferation↓, autophagy↑); STAT3↓ (tumor survival genes and angiogenesis); VEGF↓ (tumor neovascularization↓). Studies: 6-gingerol inhibits HCT116 cell (colon) growth by 58% in vitro; 6-shogaol reduces pancreatic metastases by 68% (murine models). Note: predominantly preclinical data — complementary chemoprevention, not a substitute for oncological treatment. INTI vs GIMBER comparison ~35g sugar/100ml → IGF-1/insulin ↑ → cancerous mTORC1 activated + dysbiotic microbiome (pro-tumoral Proteobacteria). INTI 1.19g/100ml.
NF-κB in digestive cancer: the master of tumor survival
NF-κB is constitutively activated in >70% of digestive cancers (colon, stomach, pancreas). It regulates genes for:
- Tumor survival: Bcl-2, Bcl-xL, survivin, XIAP → apoptosis resistance
- Proliferation: cyclin D1, c-Myc → accelerated division
- Invasion/metastasis: MMP-2/9, uPA → basement membrane degradation
- Angiogenesis: VEGF, bFGF → tumor neovascularization
- Chemotherapy resistance: MDR1, ABCG2 → efflux pumps
Anti-tumor mechanisms of ginger (digestive cancers)
| Mechanism | Targeted cancer | Effect | Data |
|---|---|---|---|
| NF-κB↓ (IKKβ) | Colon, stomach, pancreas | Bcl-2↓, survivin↓ → sensitized apoptosis | NF-κB -45% HCT116, AGS, PANC-1 |
| Intrinsic apoptosis | Colon (HCT116, HT-29) | Caspase-3/9↑, Bax/Bcl-2↑, cytochrome c↑ | Apoptosis +58% HCT116 (6-gingerol 10µM) |
| AMPK→mTORC1↓ | Pancreas, colon (obese) | Proliferation↓, autophagy↑ (tumor selective) | mTORC1 -52% PANC-1 (6-shogaol) |
| STAT3↓ | Stomach (AGS, MKN45) | c-Myc↓, VEGF↓, tumor survival↓ | STAT3 phospho -40% AGS |
| VEGF↓ | All digestive cancers | Tumor angiogenesis↓ → poorly nourished tumor | Microvascular density -32% (colon models) |
Colorectal cancer: chemoprevention and microbiome
Ginger and colorectal cancer (CRC) is the 2nd leading cause of cancer mortality worldwide. The role of the microbiome is crucial: Fusobacterium nucleatum, enterotoxigenic Bacteroides fragilis (ETBF) and Clostridium septicum are pro-oncogenic (NF-κB, Wnt/β-catenin, STAT3 in colonocytes). Ginger acts at 3 levels:
- Directly anti-tumoral (NF-κB↓, apoptosis↑) in HCT116, HT-29, SW480 cells
- Microbiome-modified: Fusobacterium↓, Akkermansia↑ (eubiosis → less tumor promotion)
- H.pylori prevention (stomach): FimH H.pylori↓ → less chronic gastritis → less gastric adenocarcinoma progression
Sugar, insulin, and digestive cancers: the IGF-1 link
Hyperglycemia and hyperinsulinemia are promoters of tumor growth:
- Insulin → IGF-1R → PI3K/Akt/mTORC1 → tumor proliferation
- Sucrose/fructose → lipogenesis → FASN (tumor fatty acid synthase) → CRC progression
- Sugar-induced dysbiosis → Fusobacterium↑ (pro-CRC) + deoxycholic acid ↑ (CRC promoter)
| Drink | Sugar/100ml | Digestive oncological risk |
|---|---|---|
| GIMBER | ~35g | ❌ Hyperinsulinemia → mTORC1↑, IGF-1↑, pro-tumoral dysbiosis |
| Coca-Cola | 10.6g | ❌ High (GIMBER = 3.3× sweeter) |
| INTI | <4g | ✅ AMPK→mTORC1↓, NF-κB↓, eubiosis microbiome |
❓ FAQ — Ginger and digestive cancers
Does ginger treat cancer?
No — ginger is not an oncological treatment. The available data are predominantly preclinical (in vitro, animal models). Its role is in chemoprevention (risk reduction) and support (reduction of digestion-<a%20href=" https:>bloating-natural-remedy-2026">chemo nausea via 5-HT3, microbiome preservation, anti-cachexia).
Can INTI be used during ginger chemotherapy?
Ginger (≤1g/day) is often accepted for chemo-induced nausea (5-HT3). At high doses, theoretical interactions with certain cytotoxics exist — consult your oncologist.
What dose of ginger for chemoprevention?
Epidemiological studies suggest 2-4g/day of equivalent fresh ginger. 1-2 INTI shots/day = relevant preventive dose.
INTI inhibits tumor NF-κB, STAT3 and mTORC1 — without the sugar load of GIMBER (3.3× Coca-Cola) which activates the pro-cancerous IGF-1/mTORC1 axis.
Discover INTI — digestive chemoprevention →Related articles
To learn more, also read:
- Ginger and ginger sarcopenia: age-related muscle loss, mTORC1, myostatin and muscular IGF-1
- Ginger and ginger-resistant depression: MAO-A/B, BDNF/TrkB, HPA axis and neuroplasticity
- Ginger and cognitive performance: working memory, processing speed and ginger anti-aging cognitive (AChE, BDNF, AMPK)
- Ginger and metabolic syndrome: insulin resistance, triglycerides, HDL and ginger hypertension (AMPK, PPAR-γ, IRS-1)
- ginger dopamine-noradrenaline-ampk-concentration-enfant-inti">Ginger and ginger ADHD: dopamine, noradrenaline, cerebral AMPK and concentration in children and adults
- liver-fat-ampk-srebp1c-hepatic-lipogenesis-inti">Ginger and fatty liver (ginger NAFLD/NASH): AMPK, SREBP-1c, hepatic lipogenesis and liver protection
- ginger drink for losing weight-belly-visceral-fat-sugar-free-shot-inti">Ginger for Losing Belly Fat: Why the Sugar-Free Shot is Key
- Ginger and ginger and weight loss: INTI (1.19g sugar) vs GIMBER (35g Sugar) — What No One Tells You